Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Acticor-Biotech

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

Overview Structured Data Issues Contributors Activity

acticor-biotech.com

Is a

Company

Organization

Company attributes

Industry

Engineering

Biomedical engineering

Location

France

Paris

Number of Employees (Ranges)

11 – 50

Full Address

Paris Santé Cochin, 27 rue du Faubourg Saint Jacques, Paris, FR

Investors

Karista

CapHorn Invest

CapDecisif Management

Go Capital

‌

CMS Medical Venture Investment Limited

Mirae Asset Capital

Newton BioCapital

Primer Capital

...

Founded Date

2010

Total Funding Amount (USD)

19,600,000

44,300,000

Latest Funding Round Date

2018

November 6, 2019

Also Known As

Acticor Biotech

Latest Funding Type

Series B Round

Country

France

Headquarters

Paris

Other attributes

Latest Funding Round Amount (USD)

17,600,000

24,700,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Acticor-Biotech

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API